{"product_id":"scripps-advancing-cardiovascular-care-emerging-therapies-and-strategies-2026","title":"Scripps Advancing Cardiovascular Care Emerging Therapies and Strategies 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: cardiologists, electrophysiologists, and cardiac surgeons\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003eThis comprehensive continuing medical educational program is designed to equip physicians with the latest knowledge and tools for diagnosing and managing complex cardiovascular conditions. Through a focus on emerging therapies, innovative technologies, and evidence-based strategies, participants will gain practical insights to optimize patient outcomes in a variety of challenging clinical scenarios. Topics will include advancements in heart failure management, mechanical circulatory support, arrhythmia therapies, pulmonary hypertension, cardiogenic shock, and more. Upon completion of this course, participants will be better prepared to integrate cutting-edge therapies and technologies into their practice, improve diagnostic accuracy, and enhance patient-centered care for individuals with cardiovascular diseases.\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003cp\u003eAnalyze the latest evidence and clinical trial data to inform the management of heart failure, pulmonary hypertension, and cardiogenic shock.\u003c\/p\u003e\n\u003cp\u003eIdentify appropriate patient populations for innovative treatments and integrate them into personalized, multidisciplinary care plans.\u003c\/p\u003e\n\u003cp\u003eEvaluate the role of emerging therapies and technologies, including renal artery denervation, Barostim, CCM, and M-TEER, in treating cardiovascular diseases.\u003c\/p\u003e\n\u003cp\u003eDevelop systematic approaches to diagnosing complex cardiovascular conditions, including amyloidosis, hypertrophic cardiomyopathy (HCM), and cardiorenal syndrome.\u003c\/p\u003e\n\u003cp\u003eOptimize the use of advanced mechanical circulatory support devices like VA ECMO, Impella, and subcutaneous ICDs.\u003c\/p\u003e\n\u003cp\u003eImprove their understanding of the pathophysiology, clinical manifestations, and management strategies for conditions such as atrial fibrillation, ventricular tachycardia, and shock.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eBest for cardiologists, electrophysiologists, and cardiac surgeons who want advanced updates on heart failure, structural interventions, and pacing.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003e01 When to Refer to Advanced Heart Failure VIDEO PDF NOT RELEASE\u003c\/p\u003e\n\u003cp\u003e02 What’s New in HFpEF Trials\u003c\/p\u003e\n\u003cp\u003e03 Finerenone Who, When, and How\u003c\/p\u003e\n\u003cp\u003e04 Beyond GDMT Barostim and CCM\u003c\/p\u003e\n\u003cp\u003e05 Exercise Testing in Heart Failure\u003c\/p\u003e\n\u003cp\u003e06 Cardiorenal Syndrome\u003c\/p\u003e\n\u003cp\u003e07 Panel DiscussionQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e08 Role of Renal Artery Denervation\u003c\/p\u003e\n\u003cp\u003e09 Acute PE Shock\u003c\/p\u003e\n\u003cp\u003e10 TAVR in Cardiogenic Shock\u003c\/p\u003e\n\u003cp\u003e11 TTVR vs T-TEER\u003c\/p\u003e\n\u003cp\u003e12 Role of M-TEER in Cardiogenic Shock\u003c\/p\u003e\n\u003cp\u003e13 Panel DiscussionQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e14 Stages of Shock\u003c\/p\u003e\n\u003cp\u003e15 Elements of an ECPR Program\u003c\/p\u003e\n\u003cp\u003e16 Troubleshooting MCS at 1 a.m. VIDEO PDF NOT RELEASE\u003c\/p\u003e\n\u003cp\u003e17 Life Hacks for Managing VA ECMO Well\u003c\/p\u003e\n\u003cp\u003e18 Life Hacks for Managing Impella Well VIDEO PDF NOT RELEASE\u003c\/p\u003e\n\u003cp\u003e19 The Cardiogenic Shock Survivor\u003c\/p\u003e\n\u003cp\u003e20 Panel DiscussionQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e21 Amyloid Diagnosis and Treatment\u003c\/p\u003e\n\u003cp\u003e22 Therapies in ATTR-CM\u003c\/p\u003e\n\u003cp\u003e23 Therapies in AL-CM\u003c\/p\u003e\n\u003cp\u003e24 HCM Mimickers and Treatment\u003c\/p\u003e\n\u003cp\u003e25 Advanced Imaging in Cardiomyopathies\u003c\/p\u003e\n\u003cp\u003e26 The Amyloid Patient\u003c\/p\u003e\n\u003cp\u003e27 Panel DiscussionQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e28 The Different Flavors of Pulmonary Hypertension\u003c\/p\u003e\n\u003cp\u003e29 The Patient Has Pulmonary Hypertension, Now What\u003c\/p\u003e\n\u003cp\u003e30 Pulmonary Hypertension in Congenital Heart Disease\u003c\/p\u003e\n\u003cp\u003e31 CTEPH When to Refer for Surgery\u003c\/p\u003e\n\u003cp\u003e32 Panel DiscussionQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e33 Atrial Fibrillation Ablation What’s New\u003c\/p\u003e\n\u003cp\u003e34 Ventricular Tachycardia Ischemic vs. Nonischemic\u003c\/p\u003e\n\u003cp\u003e35 Leadless Pacemakers\u003c\/p\u003e\n\u003cp\u003e36 Subcutaneous ICDs\u003c\/p\u003e\n\u003cp\u003e37 Left Bundle Pacing Are We Ready\u003c\/p\u003e\n\u003cp\u003e38 Panel DiscussionQ\u0026amp;A\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405751439556,"sku":null,"price":52.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Scripps-Advancing-Cardiovascular-Care-Emerging-Therapies-and-Strategies-2026.jpg?v=1784215654","url":"https:\/\/medicalcoursespro.com\/products\/scripps-advancing-cardiovascular-care-emerging-therapies-and-strategies-2026","provider":"Medicalcoursespro","version":"1.0","type":"link"}